Profund Advisors LLC Has $1.13 Million Stock Position in Cigna Group $CI

Profund Advisors LLC lessened its stake in shares of Cigna Group (NYSE:CIFree Report) by 8.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,412 shares of the health services provider’s stock after selling 333 shares during the period. Profund Advisors LLC’s holdings in Cigna Group were worth $1,128,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Flaharty Asset Management LLC bought a new position in shares of Cigna Group in the first quarter valued at $28,000. 1248 Management LLC bought a new stake in Cigna Group during the first quarter worth $29,000. Solstein Capital LLC acquired a new stake in Cigna Group in the second quarter valued at $29,000. Chilton Capital Management LLC bought a new position in shares of Cigna Group in the 2nd quarter valued at about $30,000. Finally, Activest Wealth Management increased its stake in shares of Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. TD Cowen cut their target price on shares of Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Barclays decreased their target price on Cigna Group from $383.00 to $300.00 and set an “overweight” rating on the stock in a research report on Friday, October 31st. Zacks Research cut Cigna Group from a “hold” rating to a “strong sell” rating in a report on Monday, November 3rd. The Goldman Sachs Group decreased their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a report on Tuesday, November 4th. Finally, Wells Fargo & Company dropped their target price on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a report on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.73.

View Our Latest Analysis on Cigna Group

Cigna Group Trading Up 3.7%

Shares of NYSE:CI opened at $267.82 on Wednesday. The business’s 50 day simple moving average is $291.71 and its 200 day simple moving average is $302.28. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The company has a market capitalization of $71.54 billion, a P/E ratio of 14.62, a P/E/G ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio is presently 26.64%.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This represents a 9.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.